Effect of Digital Storytelling Intervention on Diabetes Self-Management in Pregnant Women With Gestational Diabetes

NCT ID: NCT06148688

Last Updated: 2023-11-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-27

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate the effect of digital storytelling intervention on diabetes self-management in women with gestational diabetes. It is a quasi-experimental study with a pretest-posttest control group.

The main hypotheses of the study are:

Digital storytelling has an impact on women with gestational diabetes' perception of diabetes self-management.

Digital storytelling has an impact on the diabetes self-efficacy levels of women with gestational diabetes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Women with gestational diabetes who apply to the obstetrics outpatient clinic of the hospital where the study is conducted or who have been hospitalized in the obstetrics clinic and who meet the inclusion criteria will be included in the study. As a result of the G-power analysis, the sample consisted of 21 interventions and 21 control groups. Pre-test data will be collected from pregnant women in both the control and intervention groups through scales.

In the hospital where the study was conducted, pregnant women with gestational diabetes are directed to the Endocrine outpatient clinic and receive standard training by the diabetes team. Pregnant women in the intervention group will be shown videos created in addition to the standard training of the institution where the research data were collected.

Pregnant women in the intervention group will be shown videos created in addition to the standard training of the institution where the research data were collected. Pregnant women participating in the study will be followed for four weeks. Pre-test data will be collected from pregnant women who meet the sampling criteria within the first week and how the research will proceed will be explained. Four separate videos, created specifically for each determined topic, will be sent to women daily via online environments during the first week and they will be made available for viewing. Once a week, short videos will be sent to the pregnant woman as a reminder and she will be allowed to watch them. Women will be asked to keep records of their blood sugar monitoring results for four weeks. In the fourth week, post-test data from women will be collected through scales.

Scales to be used in the research

* Introductory Information Form (pre-test)
* Diabetes Self-Efficacy Scale (pre-test/post-test)
* Perceived Diabetes Self-Management Scale (pre-test/post-test)
* International Physical Activity Questionnaire (pre-test/post-test)
* Blood Sugar Monitoring Form (post-test)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gestational Diabetes Mellitus in Pregnancy Diabetes Self Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Group

In addition to the standard training, digital story videos were watched in the intervention group. Digital story videos created in line with four main topics related to diabetes self-management were sent to women via online platforms. During the follow-up period, reminder videos were sent once a week regarding the topics. Pre-test and post-test were administered face to face.

Group Type EXPERIMENTAL

Digital Story

Intervention Type OTHER

Digital storytelling; It is used in education and training, business marketing, non-profit organizations such as libraries, community centers and museums, and health sciences education. Digital storytelling in health sciences can be a tool for patients and health science professionals to share their experiences, cope with diseases, and add a human element to health problems.

In the study, digital stories were created to increase the self-management of pregnant women with gestational diabetes. In creating a digital story; Qualitative studies involving the self-management experiences of women with gestational diabetes have been examined in the literature. Using the results of the studies, scenarios were created that included factors that facilitate and complicate diabetes self-management. The created scenarios were used in the digital storytelling initiative. A total of four long and four short digital story videos were prepared.

Control Group

The control group received only standard training.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Digital Story

Digital storytelling; It is used in education and training, business marketing, non-profit organizations such as libraries, community centers and museums, and health sciences education. Digital storytelling in health sciences can be a tool for patients and health science professionals to share their experiences, cope with diseases, and add a human element to health problems.

In the study, digital stories were created to increase the self-management of pregnant women with gestational diabetes. In creating a digital story; Qualitative studies involving the self-management experiences of women with gestational diabetes have been examined in the literature. Using the results of the studies, scenarios were created that included factors that facilitate and complicate diabetes self-management. The created scenarios were used in the digital storytelling initiative. A total of four long and four short digital story videos were prepared.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being 18 years or older
* Being diagnosed with Gestational Diabetes
* 24-32. being between weeks of pregnancy
* Having a treatment plan made after gestational diabetes diagnosis
* Volunteering to participate in the study
* Knowing how to read and write Turkish
* Not having any pregnancy complications other than Gestational Diabetes
* Having a smart phone
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ege University

OTHER

Sponsor Role collaborator

Izmir Katip Celebi University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gulsen Isık

Research Assistant

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gülşen Işık

Role: PRINCIPAL_INVESTIGATOR

Izmir Katip Celebi University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Izmir Katip Celebi University

Çiğli, İzmir, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gülşen Işık

Role: CONTACT

Phone: +902323293535

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gülşen Işık

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

21-2.1T/39

Identifier Type: -

Identifier Source: org_study_id